These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34645786)

  • 41. Comprehensive analysis of two Shank3 and the Cacna1c mouse models of autism spectrum disorder.
    Kabitzke PA; Brunner D; He D; Fazio PA; Cox K; Sutphen J; Thiede L; Sabath E; Hanania T; Alexandrov V; Rasmusson R; Spooren W; Ghosh A; Feliciano P; Biemans B; Benedetti M; Clayton AL
    Genes Brain Behav; 2018 Jan; 17(1):4-22. PubMed ID: 28753255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dormant state of quiescent neural stem cells links Shank3 mutation to autism development.
    Kim H; Cho B; Park H; Kim J; Kim S; Shin J; Lengner CJ; Won KJ; Kim J
    Mol Psychiatry; 2022 Jun; 27(6):2751-2765. PubMed ID: 35444258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of the Partial M1 Muscarinic Cholinergic Receptor Agonist CDD-0102A on Stereotyped Motor Behaviors and Reversal Learning in the BTBR Mouse Model of Autism.
    Athnaiel O; Job GA; Ocampo R; Teneqexhi P; Messer WS; Ragozzino ME
    Int J Neuropsychopharmacol; 2022 Jan; 25(1):64-74. PubMed ID: 34791301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sodium phenylbutyrate reduces repetitive self-grooming behavior and rescues social and cognitive deficits in mouse models of autism.
    Ryu YK; Park HY; Go J; Choi DH; Choi YK; Rhee M; Lee CH; Kim KS
    Psychopharmacology (Berl); 2021 Jul; 238(7):1833-1845. PubMed ID: 33723660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decrease in endogenous brain allopregnanolone induces autism spectrum disorder (ASD)-like behavior in mice: A novel animal model of ASD.
    Ebihara K; Fujiwara H; Awale S; Dibwe DF; Araki R; Yabe T; Matsumoto K
    Behav Brain Res; 2017 Sep; 334():6-15. PubMed ID: 28743598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of Trpv4 rescues circuit and social deficits unmasked by acute inflammatory response in a Shank3 mouse model of Autism.
    Tzanoulinou S; Musardo S; Contestabile A; Bariselli S; Casarotto G; Magrinelli E; Jiang YH; Jabaudon D; Bellone C
    Mol Psychiatry; 2022 Apr; 27(4):2080-2094. PubMed ID: 35022531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
    Román V; Adham N; Foley AG; Hanratty L; Farkas B; Lendvai B; Kiss B
    Psychopharmacology (Berl); 2021 Sep; 238(9):2381-2392. PubMed ID: 34264367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabis and cannabinoid use in autism spectrum disorder: a systematic review.
    Silva EAD; Medeiros WMB; Torro N; Sousa JMM; Almeida IBCM; Costa FBD; Pontes KM; Nunes ELG; Rosa MDD; Albuquerque KLGD
    Trends Psychiatry Psychother; 2022 Jun; 44():e20200149. PubMed ID: 34043900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Environmental enrichment has minimal effects on behavior in the Shank3 complete knockout model of autism spectrum disorder.
    Hulbert SW; Bey AL; Jiang YH
    Brain Behav; 2018 Nov; 8(11):e01107. PubMed ID: 30317697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting Peripheral Somatosensory Neurons to Improve Tactile-Related Phenotypes in ASD Models.
    Orefice LL; Mosko JR; Morency DT; Wells MF; Tasnim A; Mozeika SM; Ye M; Chirila AM; Emanuel AJ; Rankin G; Fame RM; Lehtinen MK; Feng G; Ginty DD
    Cell; 2019 Aug; 178(4):867-886.e24. PubMed ID: 31398341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic potential of CBD in Autism Spectrum Disorder.
    Pedrazzi JFC; Hassib L; Ferreira FR; Hallak JC; Del-Bel E; Crippa JA
    Int Rev Neurobiol; 2024; 177():149-203. PubMed ID: 39029984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study.
    Aran A; Cassuto H; Lubotzky A; Wattad N; Hazan E
    J Autism Dev Disord; 2019 Mar; 49(3):1284-1288. PubMed ID: 30382443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR/Cas9-mediated disruption of SHANK3 in monkey leads to drug-treatable autism-like symptoms.
    Tu Z; Zhao H; Li B; Yan S; Wang L; Tang Y; Li Z; Bai D; Li C; Lin Y; Li Y; Liu J; Xu H; Guo X; Jiang YH; Zhang YQ; Li XJ
    Hum Mol Genet; 2019 Feb; 28(4):561-571. PubMed ID: 30329048
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early life sleep disruption potentiates lasting sex-specific changes in behavior in genetically vulnerable Shank3 heterozygous autism model mice.
    Lord JS; Gay SM; Harper KM; Nikolova VD; Smith KM; Moy SS; Diering GH
    Mol Autism; 2022 Aug; 13(1):35. PubMed ID: 36038911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Shank3B mutant mice display pitch discrimination enhancements and learning deficits.
    Rendall AR; Perrino PA; Buscarello AN; Fitch RH
    Int J Dev Neurosci; 2019 Feb; 72():13-21. PubMed ID: 30385192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical cannabis for the treatment of comorbid symptoms in children with autism spectrum disorder: An interim analysis of biochemical safety.
    Stolar O; Hazan A; Vissoker RE; Kishk IA; Barchel D; Lezinger M; Dagan A; Treves N; Meiri D; Berkovitch M; Kohn E; Heyman E
    Front Pharmacol; 2022; 13():977484. PubMed ID: 36249785
    [No Abstract]   [Full Text] [Related]  

  • 57. The
    Gonçalves AM; Sousa N; Jacinto L; Monteiro P
    Front Behav Neurosci; 2023; 17():1205507. PubMed ID: 37693284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modeling SHANK3-associated autism spectrum disorder in Beagle dogs via CRISPR/Cas9 gene editing.
    Tian R; Li Y; Zhao H; Lyu W; Zhao J; Wang X; Lu H; Xu H; Ren W; Tan QQ; Shi Q; Wang GD; Zhang YP; Lai L; Mi J; Jiang YH; Zhang YQ
    Mol Psychiatry; 2023 Sep; 28(9):3739-3750. PubMed ID: 37848710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of Homer1a in the basal and lateral amygdala impairs fear conditioning and induces an autism-like social impairment.
    Banerjee A; Luong JA; Ho A; Saib AO; Ploski JE
    Mol Autism; 2016; 7():16. PubMed ID: 26929812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy.
    Bar-Lev Schleider L; Mechoulam R; Saban N; Meiri G; Novack V
    Sci Rep; 2019 Jan; 9(1):200. PubMed ID: 30655581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.